STAT April 29, 2024
Ed Silverman

In a challenge to the pharmaceutical industry, Doctors Without Borders has revealed the detailed costs of a study it ran for a tuberculosis treatment regimen and maintained this is the first time that expenses incurred for an individual clinical trial had been publicized.

Moreover, the charity argued that its decision should help undercut a long-standing contention by drug companies that high prices for their medicines can be justified by...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Clinical Trials, Pharma, Pharma / Biotech, Trends
Decentralized Clinical Trials for older adults: Mobile research trends and recommendations
FDA report highlights need to improve diversity in clinical trials
Long Covid: the cause, the consequence, the future of clinical trials
Ozempic can improve heart health, regardless of weight loss
STAT+: Lilly’s weekly insulin works as well as daily products, new studies show

Share This Article